Read more stories about
Montana Biotech >>

MATR Sponsor:

MATR Supporters:

Bozeman Takeda branch involved with push for Zika vaccine

September 3, 2016View for printing

Takeda announced Thursday it had received $19.8 million from the U.S. Department of Health and Human Services to develop the vaccine, with a first phase of clinical trials set for 2017.

It also says it could receive as much as $312 million in public funding if the research moves through multiple phases of trials.

By Eric Dietrich Chronicle Staff Writer

Full Story: ... fa18f1.html
No reader comments so far. Be the first to comment by clicking the button below.

Reprinted under the Fair Use doctrine of international copyright law. Full copyright retained by the original publication. In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.

E-mail this page to a friend!